🔄 Cathie Wood’s ARK rebalance (Oct 12): ARKG sold $PSNL and $CDNA, bought $CRSP, $BEAM, $NTLA, $CMPS, $GH + more. ARKW trimmed $DKNG, ARKK trimmed $META, ARKQ added $SYM. Gene editing in, select diagnostics out. Tiny weight shifts, not a call. Stage entries. 🧘 Not financial advice. #ARK #ARKG

Key Mover for Oct 6: $ARKG (▼-8.84%)
Dropped 8.84% in one day despite being up 23.60% over 63 days, an unusually sharp reversal in speculative biotech/growth.

Anomalous Activity for Oct 6: $ARKG
$ARKG shows one of the clearest divergences in the data: Capital Flow +4.9σ alongside Relative Return -4.7σ. Heavy participation arrived without price confirmation, a notable cross-sectional split.

Anomaly Analysis for Oct 6:
Cross-sectional dispersion is elevated. $CEG and $VST show rare alignment across Capital Flow, Relative Return, and Relative Gap, while muni bond ETFs remain persistent Persistence laggards. $ARKG stands out for heavy Capital Flow with Relative Return -4.7σ.

Market Observation for Oct 5:
Higher-beta themes stayed in favor, including $ARKG (+5.1%), $ARKK (+3.3%), $TQQQ (+2.6%), and crypto proxies like $GBTC (+1.7%).

Key Mover for Oct 5: $ARKG (▲5.13%)
Genomics ETF gained 5.1% on the day and is up 20.4% over 22 days and 33.3% over 63 days, showing powerful speculative leadership.

Leadership stayed concentrated in select growth and healthcare segments: biotech and genomics stood out with $ARKG +5.1%, $IBB +1.3%, and $XLV +0.6%, while software and semis retained strong multi-day momentum despite mixed daily action.

Market Observation for Sep 24:
Healthcare/biotech led, highlighted by $ARKG +5.1%, $IBB +1.3%, and strong moves in names like $ILMN and $MRNA.

That risk-on pocket extended into speculative areas like biotech and crypto proxies, including strong moves in $ARKG, $XBI, $BITO, and $GBTC over the last week. Breadth, however, was not broad-based.

Market Observation for Sep 22:
Risk appetite is selective but visible in high-beta themes, including $ARKG, $TQQQ, crypto proxies, and leveraged semiconductor ETFs.

Biotech was another clear leader, with $ARKG up 7.82%, $XBI up 2.64%, and several large single-stock breakouts. Precious metals also rallied strongly, as $GLD rose 1.69%, $SLV 3.37%, and miners outperformed.

Key Mover for Sep 17: $ARKG (▲7.82%)
Biotech growth leadership was pronounced, up 7.82% on the day, 13.68% over 5 days, and 47.23% over 63 days.

Anomalous Activity for Sep 17: $ARKG
$ARKG confirms broad biotech strength at the ETF level: Persistence +2.0σ, Capital Flow +2.8σ, Relative Return +3.2σ. That adds breadth to the positive signals seen in several underlying equities.

Anomaly Analysis for Sep 17:
Cross-sectional dispersion is elevated. $GNRC stands out with Relative Gap +15.7σ, Relative Return +7.8σ and Capital Flow +7.2σ. Refiners $MPC and $PSX show persistent Persistence strength, while $ARKG adds broad biotech upside confirmation.

🚨 Cathie Wood's ARK just rotated again (9/10): Buying $NTLA (Intellia Therapeutics) across #ARKK + #ARKG 🧬, scooping $SOLQ.U (3iQ Solana Staking ETF) into #ARKW + #ARKF ⚡, while dumping $SLMT (Brera Holdings) across three funds 📉. Gene-editing conviction meets crypto yield rotation. @CathieDWood